Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Current Assets (2016 - 2025)

Macrogenics (MGNX) has disclosed Current Assets for 14 consecutive years, with $219.9 million as the latest value for Q4 2025.

  • Quarterly Current Assets rose 1.13% to $219.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $219.9 million through Dec 2025, up 1.13% year-over-year, with the annual reading at $219.9 million for FY2025, 1.13% up from the prior year.
  • Current Assets for Q4 2025 was $219.9 million at Macrogenics, down from $232.1 million in the prior quarter.
  • The five-year high for Current Assets was $374.7 million in Q1 2021, with the low at $147.8 million in Q3 2022.
  • Average Current Assets over 5 years is $241.8 million, with a median of $222.2 million recorded in 2022.
  • The sharpest move saw Current Assets tumbled 55.84% in 2022, then skyrocketed 97.09% in 2023.
  • Over 5 years, Current Assets stood at $279.6 million in 2021, then dropped by 20.53% to $222.2 million in 2022, then grew by 13.12% to $251.3 million in 2023, then fell by 13.47% to $217.5 million in 2024, then grew by 1.13% to $219.9 million in 2025.
  • According to Business Quant data, Current Assets over the past three periods came in at $219.9 million, $232.1 million, and $204.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.